Total Payments
$551,593
2024 Payments
$150,926
Companies
22
Transactions
359
Medicare Patients
329
Medicare Billing
$140,157
Payment Breakdown by Category
Consulting$328,556 (59.6%)
Travel$82,206 (14.9%)
Research$73,438 (13.3%)
Other$39,600 (7.2%)
Education$19,774 (3.6%)
Food & Beverage$8,019 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $328,556 | 100 | 59.6% |
| Travel and Lodging | $82,206 | 129 | 14.9% |
| Unspecified | $73,438 | 10 | 13.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,600 | 5 | 7.2% |
| Education | $19,774 | 5 | 3.6% |
| Food and Beverage | $8,019 | 110 | 1.5% |
Payments by Type
General
$478,155
349 transactions
Research
$73,438
7 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ATRICURE, INC. | $289,585 | 226 | $0 (2024) |
| Pulse Biosciences, Inc. | $130,892 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $56,008 | 26 | $0 (2018) |
| Vascular Graft Solutions Inc | $19,807 | 10 | $0 (2024) |
| Sorin Group USA Inc. | $17,334 | 10 | $0 (2017) |
| HELIOS CARDIO INC | $14,000 | 7 | $0 (2024) |
| LivaNova USA, Inc. | $9,862 | 9 | $0 (2020) |
| Cyberonics, Inc. | $8,061 | 21 | $0 (2017) |
| Medtronic, Inc. | $2,675 | 9 | $0 (2024) |
| Abbott Laboratories | $1,251 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150,926 | 34 | Pulse Biosciences, Inc. ($130,892) |
| 2023 | $101,967 | 53 | ATRICURE, INC. ($87,984) |
| 2022 | $33,481 | 38 | AtriCure, Inc. ($26,867) |
| 2021 | $3,800 | 10 | Medtronic, Inc. ($2,000) |
| 2020 | $59,873 | 56 | ATRICURE, INC. ($57,910) |
| 2019 | $71,940 | 67 | AtriCure, Inc. ($70,777) |
| 2018 | $43,718 | 36 | AtriCure, Inc. ($37,839) |
| 2017 | $85,888 | 65 | Medtronic Vascular, Inc. ($55,957) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $15,284.53 | General |
| Category: Cardiology | ||||||
| 12/19/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $11,646.94 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Zimmer Biomet Holdings, Inc. | — | Food and Beverage | In-kind items and services | $43.39 | General |
| 11/27/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Travel and Lodging | Cash or cash equivalent | $3,841.00 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Pulse Biosciences, Inc. | CellFx (Device) | Consulting Fee | Cash or cash equivalent | $16,666.67 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | ATRICURE, INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 08/29/2024 | ATRICURE, INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 08/29/2024 | ATRICURE, INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 08/26/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2024 | Medtronic, Inc. | AVALUS (Device) | Food and Beverage | In-kind items and services | $167.37 | General |
| Category: Heart Valves | ||||||
| 07/19/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $131.20 | General |
| 07/19/2024 | Medtronic, Inc. | AVALUS (Device) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Heart Valves | ||||||
| 07/17/2024 | HELIOS CARDIO INC | CARDIAMEND (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2024 | Medtronic, Inc. | AVALUS (Device) | Food and Beverage | In-kind items and services | $163.33 | General |
| Category: Heart Valves | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONGSTANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUM ENDO/EPICARDIAL CARDIAC SURGERY | AtriCure, Inc. | $41,536 | 2 |
| AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery | AtriCure, Inc. | $27,114 | 2 |
| Believe APR002 Clinical Study | LivaNova USA, Inc. | $2,100 | 1 |
| Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant | LivaNova USA, Inc. | $1,900 | 1 |
| ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUMP ENDO/EPICARDIAL CARDIAC SURGERY | AtriCure, Inc. | $787.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 80 | 80 | $140,515 | $29,019 |
| 2021 | 6 | 178 | 180 | $291,618 | $80,042 |
| 2020 | 5 | 71 | 71 | $89,803 | $31,096 |
Total Patients
329
Total Services
331
Medicare Billing
$140,157
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2022 | 30 | 30 | $115,650 | $20,060 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $19,945 | $7,027 | 35.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,919 | $1,932 | 39.3% |
| 33361 | Replacement of aortic valve with prosthetic valve, accessed through the skin | Facility | 2021 | 45 | 45 | $173,475 | $31,861 | 18.4% |
| 33533 | Heart artery bypass, single graft | Facility | 2021 | 17 | 17 | $73,693 | $29,889 | 40.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 51 | 51 | $24,598 | $9,727 | 39.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 31 | $12,959 | $5,643 | 43.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 17 | $6,180 | $2,645 | 42.8% |
| 33508 | Harvest of veins for coronary artery bypass procedure using an endoscope | Facility | 2021 | 19 | 19 | $712.88 | $278.16 | 39.0% |
| 33533 | Heart artery bypass to repair one artery | Facility | 2020 | 16 | 16 | $69,432 | $24,092 | 34.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 18 | $7,236 | $3,342 | 46.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $5,628 | $2,253 | 40.0% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2020 | 12 | 12 | $7,020 | $1,204 | 17.2% |
| 33508 | Harvest of veins for coronary artery bypass procedure using an endoscope | Facility | 2020 | 13 | 13 | $487.76 | $205.01 | 42.0% |
About Dr. Niv Ad, M.D
Dr. Niv Ad, M.D is a Surgery healthcare provider based in Takoma Park, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982673364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niv Ad, M.D has received a total of $551,593 in payments from pharmaceutical and medical device companies, with $150,926 received in 2024. These payments were reported across 359 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($328,556).
As a Medicare-enrolled provider, Ad has provided services to 329 Medicare beneficiaries, totaling 331 services with total Medicare billing of $140,157. Data is available for 3 years (2020–2022), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Thoracic Surgery (Cardiothoracic Vascular Surgery), Specialist
- Location Takoma Park, MD
- Active Since 03/16/2006
- Last Updated 03/31/2017
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1982673364
Products in Payments
- CellFx (Device) $130,892
- ATRICURE SYNERGY ABLATION SYSTEM (Device) $60,212
- ATRICURE SYNERGY ABLATION SYSTEMS (Device) $41,536
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $32,050
- Aortic Tissue Valve - Perceval (Device) $31,240
- AtriCure Cryosurgical System (Device) $28,543
- SYNERGY ABLATION SYSTEM (Device) $27,175
- EPi-Sense Guided Coagulation System with VisiTrax (Device) $20,121
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) $18,338
- CryoFlex (Device) $17,478
- CARDIAMEND (Device) $14,000
- VIOLA (Device) $13,577
- Cardioblate (Device) $9,869
- VEST (Device) $6,230
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $4,618
- CoreValve Evolut (Device) $2,154
- ATRICURE ATRICLIP LAA EXCLUSION (Device) $2,107
- Aortic Tissue Valve - Crown PRT (Device) $2,100
- Perceval (Device) $1,900
- ACC2 CARDIAC CRYOSURGICAL SYSTEM (Device) $1,784
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.